NCT04634812View on ClinicalTrials.gov

Mass Balance Study of KBP-5074 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

December 3, 2020

Primary Completion Date

December 23, 2020

Study Completion Date

December 23, 2020

Conditions

Healthy

Interventions

DRUG

KBP-5074

a single oral dose of \[14C\]-KBP-5074

Trial Locations (1)

53704

Covance Clinical Research Unit Inc., Madison

Sponsors

Lead Sponsor

KBP Biosciences

Collaborators (1)

All Listed Sponsors

collaborator

Covance

INDUSTRY

lead

KBP Biosciences

INDUSTRY